Taxus Pharmaceuticals, Inc. - FORM S-1/A - EX-23 - AUDITOR CONSENT - September 30, 2013

Attached files

file filename
S-1/A - AMENDMENT NO.5 TO FORM S-1 - Taxus Pharmaceuticals, Inc.taxusforms1amendmentno5v3tra.htm
EX-5 - US LEGAL OPINION - Taxus Pharmaceuticals, Inc.ex51uslegalopinion.htm
EX-5 - CHINESE LEGAL OPINION - Taxus Pharmaceuticals, Inc.ex52chineselegalopinion.htm
EX-99 - AUDITED ANNUAL FINANCIAL STATEMENTS - Taxus Pharmaceuticals, Inc.ex991taxuspharmaceuticalsfsa.htm
EX-99 - UNAUDITED INTERIM FINANCIAL STATEMENTS - Taxus Pharmaceuticals, Inc.ex992taxuspharmaceuticalsfsa.htm
EX-5 - CHINESE LEGAL COUNSEL CONSENT - Taxus Pharmaceuticals, Inc.ex53chineselegalcounselconse.htm

[ex231auditorconsent001.jpg]




CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the use in the amendment to the Registration Statement (Form S-1/A) pertaining to the registration of 862,000 shares of common stock of Taxus Pharmaceuticals, Inc., of our report dated May 30, 2013 (Except for Note 2, 6, 18 and 19 as to which the date is September 27, 2013) with respect to the financial statements of Taxus Pharmaceuticals, Inc for the years ended December 31, 2012 and 2011. We also consent to the reference to us under the heading “Experts” in the above referenced Registration Statement.




/s/ Patrizio & Zhao, LLC


Certified Public Accountants and Consultants


Parsippany, New Jersey

September 27, 2013